BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35761837)

  • 21. The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast.
    Ao F; Yan Y; Zhang ZL; Li S; Li WJ; Chen GB
    Acta Radiol; 2022 Jul; 63(7):891-900. PubMed ID: 34134527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
    Tezcan S; Ozturk FU; Uslu N; Akcay EY
    Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved performance in differentiating benign from malignant sinonasal tumors using diffusion-weighted combined with dynamic contrast-enhanced magnetic resonance imaging.
    Wang XY; Yan F; Hao H; Wu JX; Chen QH; Xian JF
    Chin Med J (Engl); 2015 Mar; 128(5):586-92. PubMed ID: 25698188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer.
    Onishi N; Sadinski M; Hughes MC; Ko ES; Gibbs P; Gallagher KM; Fung MM; Hunt TJ; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Breast Cancer Res; 2020 May; 22(1):58. PubMed ID: 32466799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maximum slope using ultrafast breast DCE-MRI at 1.5 Tesla: a potential tool for predicting breast lesion aggressiveness.
    Pelissier M; Ambarki K; Salleron J; Henrot P
    Eur Radiol; 2021 Dec; 31(12):9556-9566. PubMed ID: 34117556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma.
    Xi Y; Yuan Q; Zhang Y; Madhuranthakam AJ; Fulkerson M; Margulis V; Brugarolas J; Kapur P; Cadeddu JA; Pedrosa I
    Eur Radiol; 2018 Jan; 28(1):124-132. PubMed ID: 28681074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between voxel-wise enhancement parameters on DCE-MRI and pathological prognostic factors in invasive breast cancers.
    Trimboli RM; Codari M; Khouri Chalouhi K; Ioan I; Lo Bue G; Ottini A; Casolino D; Carbonaro LA; Sardanelli F
    Radiol Med; 2018 Feb; 123(2):91-97. PubMed ID: 28948442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment response assessment of breast masses on dynamic contrast-enhanced magnetic resonance scans using fuzzy c-means clustering and level set segmentation.
    Shi J; Sahiner B; Chan HP; Paramagul C; Hadjiiski LM; Helvie M; Chenevert T
    Med Phys; 2009 Nov; 36(11):5052-63. PubMed ID: 19994516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
    Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
    Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multilevel analysis of spatiotemporal association features for differentiation of tumor enhancement patterns in breast DCE-MRI.
    Lee SH; Kim JH; Cho N; Park JS; Yang Z; Jung YS; Moon WK
    Med Phys; 2010 Aug; 37(8):3940-56. PubMed ID: 20879557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The actions of diffusion weighted imaging (DWI) and dynamic contrast enhanced MRI in differentiating breast tumors].
    Luo Y; Yu J; Chen D; Xu Z; Zeng H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Dec; 30(6):1219-23. PubMed ID: 24645600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of Benign From Malignant Sinonasal Masses Using Diffusion Weighted Imaging and Dynamic Contrast Enhanced Magnetic Resonance Imaging.
    Daga R; Kumar J; Pradhan G; Meher R; Malhotra V; Khurana N
    Am J Rhinol Allergy; 2022 Mar; 36(2):207-215. PubMed ID: 34486401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
    Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
    Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Qualitative characterization of breast tumors with diffusion-weighted imaging has comparable accuracy to quantitative analysis.
    Kul S; Metin Y; Bekircavusoglu S; Kul M
    Clin Imaging; 2021 Sep; 77():17-24. PubMed ID: 33639496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
    Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
    Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.
    Song C; Cheng P; Cheng J; Zhang Y; Sun M; Xie S; Zhang X
    Eur Radiol; 2020 Jan; 30(1):110-118. PubMed ID: 31372786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computer-aided diagnosis of breast DCE-MRI using pharmacokinetic model and 3-D morphology analysis.
    Wang TC; Huang YH; Huang CS; Chen JH; Huang GY; Chang YC; Chang RF
    Magn Reson Imaging; 2014 Apr; 32(3):197-205. PubMed ID: 24439361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.